Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
Sasha Hubschman, 1 Michael J Venincasa, 1 Ajay E Kuriyan, 2 Jayanth Sridhar 1 1Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA; 2Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Roches...
Guardado en:
Autores principales: | Hubschman S, Venincasa MJ, Kuriyan AE, Sridhar J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c588af2ed6e44b10b08a9c7c7de94ede |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ocriplasmin: who is the best candidate?
por: Prospero Ponce CM, et al.
Publicado: (2016) -
Clinical characteristics and selection of treatment modality for patients with vitreomacular traction: real-world implementation of NICE guidance (TA297)
por: Pritchard EWJ, et al.
Publicado: (2016) -
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
por: Drenser KA, et al.
Publicado: (2021) -
Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting
por: Reichel E, et al.
Publicado: (2016) -
Clinical Features of Vitreomacular Traction Syndrome with Peripheral Vitreoretinal Adhesion
por: Fukumoto M, et al.
Publicado: (2020)